News tagged with thiazolidinediones
Botanical compound could prove crucial to healing influenza
Building on previous work with the botanical abscisic acida, researchers in the Nutritional Immunology and Molecular Medicine Laboratory (NIMML) have discovered that abscisic acid has anti-inflammatory effects in the lungs ...
Medical research
Jul 18, 2012 |
not rated yet |
0
|
Diabetes drug side effects traced to fat action
For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone (trade name Avandia) has been in the spotlight for its possible link to increased cardiovascular events, ...
Medical research
Jul 05, 2011 |
not rated yet |
0
|
Popular diabetes drugs' cardiovascular side effects explained
Drugs known as thiazolidinediones, or TZDs for short, are widely used in diabetes treatment, but they come with a downside. The drugs have effects on the kidneys that lead to fluid retention as the volume of plasma in the ...
Medical research
May 03, 2011 |
not rated yet |
0
|
Use of more costly diabetes medications varies widely
(HealthDay)—Even within an integrated Veterans Affairs (VA) system with a uniform national formulary and established criteria for drug use, there is substantial variation in the use of thiazolidinediones ...
Diabetes
Oct 12, 2012 |
not rated yet |
0
Some diabetes drugs may increase risk of bladder cancer
An increased risk of bladder cancer is linked to the use of pioglitazone, a medication commonly used to treat type 2 diabetes, according to a new study published in CMAJ (Canadian Medical Association Journal).
Cancer
Jul 03, 2012 |
5 / 5 (1) |
0
Thiazolidinedione use in patients with Type 2 diabetes may increase risk for diabetic macular edema
Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year ...
Diabetes
Jun 11, 2012 |
not rated yet |
0
Thiazolidinediones tied to lower cancer risk in diabetes patients
(HealthDay) -- Thiazolidinediones are associated with a lower risk of liver and colorectal cancer in patients with type 2 diabetes, according to a study published in the May issue of Hepatology.
Cancer
Apr 27, 2012 |
not rated yet |
0